Phase I/II trial of sorafenib and CCI-779 in patients with recurrent glioblastoma (GBM)

Jaeckle, K. ,  Anderson, K. ,  Sarkaria, J. ,  Decker, P. ,  Buckner, J. ... -  ICTT -  -  2008  

Abstract -  Primary Endpoint -  Preliminary Analysis -  Neuro-Onc -  NCCTG-N0572